Profile data is unavailable for this security.
About the company
Medtronic plc is a global healthcare technology company. The Company develops, manufactures, and markets its medical devices and technologies to hospitals, physicians, clinicians, and patients. Its operating segments include Cardiovascular, Medical Surgical, Neuroscience and Diabetes. Cardiovascular products include pacemakers, insertable cardiac monitors, and cardiac resynchronization therapy devices. Medical Surgical products include patient care from diagnosis to recovery, with a focus on diseases of the gastrointestinal tract, lungs, pelvic region, kidneys, obesity, and preventable complications. Neuroscience products include various spinal implants, bone graft substitutes, biologic products, image-guided surgery and intra-operative imaging systems. Diabetes products include insulin pumps, continuous glucose monitoring (CGM) systems, consumables, and smart insulin pen systems. It also provides PROPEL and SINUVA. The Company is focused on cardiac ablation portfolio.
- Revenue in USD (TTM)30.77bn
- Net income in USD4.06bn
- Incorporated2014
- Employees95.00k
- LocationMedtronic PLC20 On Hatch, Hatch Street LowerDUBLIN 2IrelandIRL
- Phone+353 14381700
- Websitehttps://www.medtronic.com/
Mergers & acquisitions
Acquired company | MDT:NYQ since announced | Transaction value |
---|---|---|
Cathworks Ltd | -5.87% | -- |